CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

11 hedge funds and large institutions have $3.12M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.35M
2
+$978K
3
+$693K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
+$29K
5
UBS Group
UBS Group
Switzerland
+$25K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.35M
2
$978K
3
$693K
4
$29K
5
$25K
6
$11K
7
$7K
8
$6K
9
$5K
10
$3K
11
$3K